MLYSMineralys Therapeutics, Inc.

$20.54-52% 1Y

Is the business good?

How good a business is MLYS?

Share count, year on year
+29%

Share count, year on year · shareholders own a smaller slice than a year ago

Details›
Net income, trailing twelve months
−$350M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.